DCO

Decoy Therapeutics Inc. Common Stock

DCOY • NASDAQ

Decoy Therapeutics Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Frederick E. Pierce, with a market cap of $3.1M.

Market Cap$3.1M

CEOFrederick E. Pierce

CountryUnited States of America

PHARMACEUTICAL PREPARATIONS

Next EarningsMay 13, 2026 · In 2 weeksAfter Market Close · Q1 2026

Income Statement Balance Sheet Cash Flow Business Segments

Financials

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

DCO

Decoy Therapeutics Inc. Common Stock FAQ

Common questions about Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 13, 2026 after market close.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.